Lacob Joseph S.'s most recent trade in NeuroPace Inc was a trade of 8,745 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 8,745 | 8,745 | - | - | Stock Option (right to buy) | |
| Align Tech | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 1,745 | 1,745 | - | - | Restricted Stock Units | |
| Align Tech | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 1,148 | 0 | - | - | Restricted Stock Units | |
| Align Tech | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 1,148 | 134,171 (0%) | 0% | 0 | Common Stock | |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 17,774 | 17,774 | - | - | Stock Option (Rt to Buy) | |
| Align Tech | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,148 | 1,148 | - | - | Restricted Stock Units | |
| Align Tech | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 1,029 | 133,023 (0%) | 0% | 0 | Common Stock | |
| Align Tech | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 1,029 | 0 | - | - | Restricted Stock Units | |
| Align Tech | Lacob S. Joseph | Director | Sale of securities on an exchange or to another person at price $ 302.97 per share. | 27 Feb 2024 | 10,524 | 136,470 (0%) | 0% | 303.0 | 3,188,507 | Common Stock |
| Align Tech | Lacob Joseph S. | Director | Sale of securities on an exchange or to another person at price $ 313.01 per share. | 27 Feb 2024 | 10,000 | 146,994 (0%) | 0% | 313.0 | 3,130,075 | Common Stock |
| Align Tech | Joseph Lacob S. | Director | Sale of securities on an exchange or to another person at price $ 303.59 per share. | 27 Feb 2024 | 3,676 | 132,794 (0%) | 0% | 303.6 | 1,115,996 | Common Stock |
| Align Tech | Joseph Lacob S. | Director | Sale of securities on an exchange or to another person at price $ 304.76 per share. | 27 Feb 2024 | 800 | 131,994 (0%) | 0% | 304.8 | 243,805 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 4.49 per share. | 30 Jun 2023 | 2,505 | 2,889 | - | 4.5 | 11,247 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 6.97 per share. | 30 Jun 2023 | 1,614 | 9,090 | - | 7.0 | 11,250 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 7.56 per share. | 30 Jun 2023 | 1,488 | 7,476 | - | 7.6 | 11,249 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 9.73 per share. | 30 Jun 2023 | 1,156 | 4,045 | - | 9.7 | 11,248 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 10.31 per share. | 30 Jun 2023 | 1,091 | 5,136 | - | 10.3 | 11,248 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 10.41 per share. | 30 Jun 2023 | 1,080 | 12,080 | - | 10.4 | 11,243 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 11.53 per share. | 30 Jun 2023 | 975 | 10,065 | - | 11.5 | 11,242 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 12.02 per share. | 30 Jun 2023 | 935 | 11,000 | - | 12.0 | 11,239 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 13.20 per share. | 30 Jun 2023 | 852 | 5,988 | - | 13.2 | 11,246 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 27,380 | 27,380 | - | - | Stock Option (Rt to Buy) | |
| Align Tech | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,114 | 156,994 (0%) | 0% | 0 | Common Stock | |
| Align Tech | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,114 | 0 | - | - | Restricted Stock Unit | |
| Align Tech | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 1,029 | 1,029 | - | - | Restricted Stock Unit | |
| NeuroPace Inc | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2022 | 192 | 0 | - | - | Stock Option (Rt to Buy) | |
| NeuroPace Inc | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 18 Oct 2022 | 192 | 384 | - | 0.0 | 5 | Common Stock |
| NeuroPace Inc | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 18,253 | 18,253 | - | - | Stock Option (Right to Buy) | |
| Align Tech | Joseph S. Lacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 1,114 | 1,114 | - | - | Restricted Stock Unit | |
| Align Tech | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 524 | 155,880 (0%) | 0% | 0 | Common Stock | |
| Align Tech | Joseph S. Lacob | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 524 | 0 | - | - | Restricted Stock Unit |